The 4717C > G polymorphism in periplakin modulates sensitivity to EGFR inhibitors
The use of EGFR inhibitors on oral squamous cell carcinoma (OSCC) as monotherapy yielded modest clinical outcomes and therefore would benefit from biomarkers that could predict which patient subsets are likely to respond. Here, we determined the efficacy of erlotinib in OSCC cell lines, and by compa...
Saved in:
Main Authors: | Lee, Hui Mei, Kelly, Gregory Michael, Zainal, Nur Syafinaz, Yee, Pei San, Fadlullah, Muhammad Zaki Hidayatullah, Lee, Bernard Kok Bang, Gan, Chai Phei, Patel, Vyomesh, Cheong, Sok Ching |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Research
2019
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/23887/1/s41598-019-38742-0.pdf http://eprints.um.edu.my/23887/ https://www.nature.com/articles/s41598-019-38742-0.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular docking analysis on the designed benzimidazole derivatives as EGFR inhibitors: comparison between EGFR wild-type (EGFRWT) and T790M mutant
by: Nurul Awani Syazzira Jalil,, et al.
Published: (2023) -
Molecular Docking analysis on the designed Benzimidazole derivatives as EGFR inhibitors: comparison between EGFR Wild-Type (EGFRWT) and T790M Mutant
by: Jalil, Nurul Awani Syazzira, et al.
Published: (2023) -
Automated in silico EGFR peptide inhibitor elongation using self-evolving peptide algorithm
by: Tan, Ke Han, et al.
Published: (2022) -
Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors
by: Chai, Chee Shee, et al.
Published: (2019) -
Effects of palbociclib on oral squamous cell carcinoma and the role of PIK3CA in conferring resistance
by: Zainal, Nur Syafinaz, et al.
Published: (2019)